retatrutide triple agonist gip glp-1 glucagon Synedica Retatrutide (4 x 10mg Vial)

The Alpha-Cell as Target for Type 2 Diabetes Therapy

Epac, exchange protein directly activated by cyclic adenosine monophosphate

Free testosterone levels drop significantly during treatment, and these benefits often remain stable even after stopping GLP-1 therapy, provided metformin is continued

WEDNESDAY, June 10, 2026 (HealthDay News) -- Continuation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) into early pregnancy seems not to be associated with the risk for nonlive birth, abnormal fetal growth, or major congenital malformation (MCM), according to a study published online June 9 in the Annals of Internal Medicine.Jeremy P

ALTERNATIVES TO BIRTH CONTROL PILLS Patients concerned about interactions between GLP-1 medications and birth control should talk to their care providers to make sense of manufacturer recommendations and learn about alternatives to oral contraceptives

doi: 10.1016/j.npep.2018.07.003 76 BrauerRWeiLMaTAthaudaDGirgesCVijiaratnamNet al